Sunesis Pharmaceuticals (Nasdaq: SNSS) announced that the Pediatric Committee of the European Medicines Agency (EMA) has issued a positive opinion ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE